Van Leeuwen & Company’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-14,735
Closed -$2.44M 82
2020
Q4
$2.44M Sell
14,735
-12,032
-45% -$1.96M 1.63% 25
2020
Q3
$4.43M Buy
26,767
+7,695
+40% +$1.18M 3.44% 7
2020
Q2
$2.61M Sell
19,072
-6,328
-25% -$826K 2.03% 18
2020
Q1
$2.99M Buy
25,400
+7,592
+43% +$1,000K 2.87% 10
2019
Q4
$2.36M Buy
17,808
+394
+2% +$49K 1.97% 16
2019
Q3
$2.17M Sell
17,414
-752
-4% -$90.8K 2.05% 17
2019
Q2
$2.06M Sell
18,166
-4,121
-18% -$432K 1.85% 21
2019
Q1
$2.24M Sell
22,287
-582
-3% -$52.8K 2.1% 16
2018
Q4
$1.96M Buy
22,869
+18,363
+408% +$1.65M 1.96% 19
2018
Q3
$413K Buy
+4,506
New +$400K 0.38% 59

Other funds holding ZTS

Van Leeuwen & Company's ZTS Position: Q1 2021 in Review

Van Leeuwen & Company sold out of Zoetis (ZTS) in Q1 2021, closing a stake of 14,735 shares — an estimated $2.44M sold.

Van Leeuwen & Company first reported a position in ZTS in Q3 2018 and held it in 10 quarters. The position peaked at $4.43M in Q3 2020. 1,415 funds tracked by Wall St. Rank hold ZTS as of Q1 2021.

  • Van Leeuwen & Company reported no remaining Zoetis position as of Q1 2021 after selling out during the quarter.
  • Van Leeuwen & Company sold 14,735 Zoetis shares in Q1 2021, an estimated $2.44M.
  • Van Leeuwen & Company first reported a position in Zoetis in Q3 2018 and held it in 10 quarters.
  • Van Leeuwen & Company's Zoetis position peaked at $4.43M in Q3 2020.
  • 1,415 funds tracked by Wall St. Rank held Zoetis as of Q1 2021.

Based on Van Leeuwen & Company's 13F filing for Q1 2021, filed 11 May 2021.